Cargando…
Effect of a novel anti-CCR4 monoclonal antibody (Mogamulizmab) on skin lesions of adult T-cell leukemia-lymphoma (ATL) and its adverse skin reactions (ASR)
Autores principales: | Yonekura, Kentaro, Kanzaki, Tamotsu, Nakano, Nobuaki, Tokunaga, Masahito, Kubota, Ayumu, Takeuchi, Shogo, Takatsuka, Yoshifusa, Utsunomiya, Atae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044572/ http://dx.doi.org/10.1186/1742-4690-11-S1-P24 |
Ejemplares similares
-
Cutaneous adverse reactions and anti-tumor effects of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma
por: Yonekura, Kentro, et al.
Publicado: (2015) -
Presence of cutaneous lesion is a poor prognostic factor in patients with smoldering-type adult T-cell leukemia-lymphoma
por: Yonekura, Kentaro, et al.
Publicado: (2011) -
Chronic type adult T-cell leukemia-lymphoma after autolougous stem cell transplantation for ALK-negative anaplastic large cell lymphoma
por: Utsunomiya, Atae, et al.
Publicado: (2015) -
Long-term follow-up of patients with ATL after autologous stem cell transplantation
por: Utsunomiya, Atae, et al.
Publicado: (2022) -
Promising results of an anti-CCR4 antibody, KW-0761, for relapsed Adult T-Cell Leukemia-Lymphoma (ATL)
por: Utsunomiya, Atae, et al.
Publicado: (2011)